Table 1 The clinical features between TCGA stiff and soft tumor subtypes for prostate cancer patients
Characteristic | Soft tumor | Stiff tumor | P value |
|---|---|---|---|
Samples | 354 | 76 | Â |
Age, median (IQR) | 61 (56, 66) | 62 (57, 66) | 0.526 |
Gleason score, n (%) | Â | Â | 0.297 |
 6 | 32 (7.4%) | 7 (1.6%) |  |
 7 | 175 (40.7%) | 31 (7.2%) |  |
 8 | 50 (11.6%) | 9 (2.1%) |  |
 9 | 97 (22.6%) | 29 (6.7%) |  |
T stage, n (%) | Â | Â | 1.000 |
 T2 | 128 (30.2%) | 27 (6.4%) |  |
 T3 | 214 (50.5%) | 47 (11.1%) |  |
 T4 | 7 (1.7%) | 1 (0.2%) |  |
Race, n (%) | Â | Â | 0.317 |
 Asian | 9 (2.2%) | 2 (0.5%) |  |
 Black or African American | 45 (10.8%) | 5 (1.2%) |  |
 White | 288 (69.2%) | 67 (16.1%) |  |
N stage, n (%) | Â | Â | 1.000 |
 N0 | 251 (66.9%) | 55 (14.7%) |  |
 N1 | 57 (15.2%) | 12 (3.2%) |  |
Residual tumor, n (%) | Â | Â | 0.465 |
 No | 228 (54.4%) | 45 (10.7%) |  |
 Yes | 117 (27.9%) | 29 (6.9%) |  |